In PDAC mouse models, depleting CAFs that express fibroblast activation protein (FAP) not only inhibits tumor growth alone but also potentiates the efficacy of anti-CTLA-4 and anti-PD-L1 ICB antibodies [112]. This evidence concerns the gene CD274 and neoplasm.